BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+12.16%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$717M
AUM Growth
–
Cap. Flow
+$717M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
141
New
140
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Biogen
BIIB
|
$29.9M |
| 2 |
Medtronic
MDT
|
$26.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$26M |
| 4 |
Abbott
ABT
|
$23.5M |
| 5 |
Gilead Sciences
GILD
|
$22.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.27% |
| 2 | Financials | 0.88% |
| 3 | Industrials | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $29.9M | 4.17% |
+70,730
| New | +$29.9M |
|
|
2
Medtronic
MDT
$119B
| $26.5M | 3.7% |
+340,000
| New | +$26.5M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $26M | 3.63% |
+225,790
| New | +$26M |
|
|
4
Abbott
ABT
$231B
| $23.5M | 3.28% |
+507,000
| New | +$23.5M |
|
|
5
Gilead Sciences
GILD
$140B
| $22.9M | 3.2% |
+233,810
| New | +$22.9M |
|
|
CTRX
6
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $18.9M | 2.63% |
+250,440
| New | +$18.9M |
|
7
Amgen
AMGN
$155B
| $17.6M | 2.45% |
+109,866
| New | +$17.6M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $14.5M | 2.02% |
+48,730
| New | +$14.5M |
|
9
UnitedHealth
UNH
$281B
| $13.6M | 1.9% |
+115,000
| New | +$13.6M |
|
10
Stryker
SYK
$150B
| $13.4M | 1.87% |
+145,700
| New | +$13.4M |
|
11
Regeneron Pharmaceuticals
REGN
$61.5B
| $12.9M | 1.8% |
+28,595
| New | +$12.9M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.6M | 1.76% |
+72,746
| New | +$12.6M |
|
|
ESRX
13
DELISTED
Express Scripts Holding Company
ESRX
| $12.1M | 1.69% |
+140,000
| New | +$12.1M |
|
|
CYTO
14
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $11.6M | 1.62% |
+2,169,625
| New | +$11.6M |
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $11.4M | 1.58% |
+101,000
| New | +$11.4M |
|
16
Zimmer Biomet
ZBH
$21B
| $11.2M | 1.57% |
+95,500
| New | +$11.2M |
|
17
Vertex Pharmaceuticals
VRTX
$100B
| $11M | 1.54% |
+93,500
| New | +$11M |
|
|
ENDP
18
DELISTED
Endo International plc
ENDP
| $10.4M | 1.45% |
+116,000
| New | +$10.4M |
|
19
Illumina
ILMN
$15.8B
| $10.3M | 1.44% |
+55,559
| New | +$10.3M |
|
20
Jazz Pharmaceuticals
JAZZ
$7.75B
| $10.1M | 1.41% |
+58,500
| New | +$10.1M |
|
|
STJ
21
DELISTED
St Jude Medical
STJ
| $9.88M | 1.38% |
+151,000
| New | +$9.88M |
|
22
Viatris
VTRS
$12.3B
| $9.79M | 1.37% |
+165,000
| New | +$9.79M |
|
|
KITE
23
DELISTED
Kite Pharma, Inc.
KITE
| $9.69M | 1.35% |
+168,000
| New | +$9.69M |
|
24
Baxter International
BAX
$12.7B
| $9.56M | 1.33% |
+139,500
| New | +$9.56M |
|
25
Centene
CNC
$14.3B
| $9.4M | 1.31% |
+132,920
| New | +$9.4M |
|